Luis Fonseca

• Spearhead business operations and market expansion across Latin America and Canada, leading market entry initiatives in key regions while managing a $20M P&L. • Developed a 5-year strategic roadmap defining portfolio expansion priorities, optimizing go-to-market strategies, and establishing robust channel partnerships. • Led reimbursement and market access strategies to maximize adoption of therapies for pulmonary embolism and deep vein thrombosis, leveraging clinical and health economics data.

• Managed commercial operations for Latin America, overseeing a $50M P&L and leading a 25-member team while executing a long-term strategic growth plan. • Designed and implemented a region-wide portfolio and distribution strategy, refining pricing models and partner training programs to enhance performance. • Developed a 5-year business strategy focused on scalability, portfolio diversification, and market share gains, delivering consecutive years of double-digit revenue growth.

• Led commercial, operational, and marketing functions to launch Abbott’s Digital Health Solutions business in Latin America and Canada, managing a $25M P&L. • Built a Consulting & Solutions practice, optimizing operational workflows and pricing models to accelerate early-stage market adoption. • Oversaw sales execution and market expansion, collaborating with product development teams and channel partners to drive localization and adoption.

• Managed all commercial operations and sales force effectiveness initiatives across Latin America and Canada, supporting leadership in overseeing a $400M+ P&L. • Established data-driven performance monitoring frameworks and standardized regional business planning to enhance financial outcomes. • Designed and implemented an advanced salesforce training program to transition teams toward consultative solution selling.

• Led strategic planning, sales execution, and market expansion for the Covidien Vascular Therapies portfolio in Latin America, managing an $80M+ P&L. • Directed the integration of ev3 and Maya Medical acquisitions, aligning distribution networks and regulatory strategies to maximize portfolio synergies. • Developed a 7-year regional growth strategy aimed at scaling the VT business to $250M.

• Managed the Latin America division of Medtronic’s Cardiac Rhythm business, leading a 150-member team and overseeing a $120M+ P&L. • Executed a 5-year growth plan that delivered 3 consecutive years of double-digit revenue expansion across 20+ countries. • Led portfolio strategy and channel optimization, ensuring effective pricing models and training programs for institutional and practitioner-driven demand.

• Spearheaded the turnaround and rapid growth of Medtronic’s full product portfolio across Mexico and Central America, overseeing a 65-member team. • Led a regional expansion strategy that delivered 3 consecutive years of double-digit growth across all business segments.

Responsible for the Sales & Mktg management of Corids Business Unit's four product lines - Cardiology, Endovascular, Biosense Webster and Neuroradiology. Designed and Implemented a new operational and organizational model that together with rebuilding of key customers and market ecosystem partners relationships. Two years in a row achieved the biggest YoY growth rate in Latin America.

Responsible for Sales & Marketing development of the Communications Sector in Mexico as well as the initial developments of Mobile and Embedded Devices with Microsoft Platform in the local market. Relationship development and Sales responsibility for accounts like Telmex, Telcel, Avantel, Telefónica, Alestra and others.

The Double Executive Master’s in Health Policy leverages the University of Chicago Harris School of Public Policy’s expertise in health economics and public policy and the London School of economics’ focus on global health and policy to support end-to-end thinking around solutions to challenges facing the health sector. Tailored to serve ambitious, mid-career health professionals around the world, the Double executive Master’s in Health Policy is designed to complement the body of knowledge of practitioners working in the healthcare and health-related industries with a strong foundation in global health policy and economics.